Eli Lilly and Company (NYSE:LLY – Get Free Report) was downgraded by research analysts at StockNews.com from a “buy” rating ...

Global pharma giant Eli Lilly plans to launch its diabetes and obesity treatment, tirzepatide, marketed under the brands ...

The FDA approves Zepbound, originally used for type 2 diabetes and weight loss, for treating obstructive sleep apnea (OSA) in obese adults. Developed by Eli Lilly, this drug offers an alternative to ...

Innovation, artificial intelligence, drug costs and shortages, private equity interests, and more left their mark in ...

The result: The United Nations says that, at best, it will be able to raise enough money to help about 60% of the 307 million people it predicts will need humanitarian aid next year. That means at ...

Eli Lilly's obesity drug, Mounjaro, has been approved for public availability in Britain's NHS, expanding from its initial ...

Leveraging insights from OpenAI’s ChatGPT, Finbold has curated a $1,000 stock portfolio designed to capture growth ...

Anthony Albanese joins survivors from Darwin and around the country to mark five decades since Cyclone Tracy, one of the worst natural disasters in Australian history.